H.R. 2739: Cancer Drug Coverage Parity Act of 2015

To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for anticancer medications administered by a health care provider.

The bill’s titles are written by its sponsor.

What you can do



Jun 11, 2015


Referred to Committee on Jun 11, 2015

This bill was assigned to a congressional committee on June 11, 2015, which will consider it before possibly sending it on to the House or Senate as a whole.


Leonard Lance

Representative for New Jersey's 7th congressional district



Read Text »
Last Updated: Jun 11, 2015
Length: 5 pages


1% chance of being enacted according to PredictGov (details)


Jun 11, 2015

This is the first step in the legislative process.

Reported by Committee

Passed House

Passed Senate

Signed by the President

H.R. 2739 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2739 — 114th Congress: Cancer Drug Coverage Parity Act of 2015.” www.GovTrack.us. 2015. October 26, 2016 <https://www.govtrack.us/congress/bills/114/hr2739>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.